U.S. Physical Therapy, Inc. (USPH) To Go Ex-Dividend on November 17th

U.S. Physical Therapy, Inc. (NYSE:USPH) declared a quarterly dividend on Wednesday, November 5th. Shareholders of record on Monday, November 17th will be given a dividend of 0.45 per share on Friday, December 12th. This represents a c) dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Monday, November 17th.

U.S. Physical Therapy has increased its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 6 consecutive years. U.S. Physical Therapy has a dividend payout ratio of 61.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $2.93 per share next year, which means the company should continue to be able to cover its $1.80 annual dividend with an expected future payout ratio of 61.4%.

U.S. Physical Therapy Trading Down 11.9%

Shares of USPH stock opened at $77.56 on Friday. The company’s 50-day moving average price is $85.61 and its 200-day moving average price is $79.93. U.S. Physical Therapy has a twelve month low of $62.77 and a twelve month high of $101.19. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 4.41 and a beta of 1.47.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share for the quarter. The business had revenue of $140.66 million during the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. As a group, equities analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on USPH shares. Barrington Research restated an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a report on Friday, October 24th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. JPMorgan Chase & Co. initiated coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price objective on the stock. Wall Street Zen cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. Finally, Zacks Research raised U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $110.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.